文献速递临床试验与 GCP流行病学与生物统计

评估基于POC-CCA检测的吡喹酮治疗用于孕妇及其幼儿血吸虫病控制的整群随机对照试验:马达加斯加freeBILy临床试验研究方案

A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar.
PubMed 文献 · Trials · 2021-11-20

该整群随机对照III期试验在马达加斯加40个初级卫生保健中心纳入5200名孕妇及其后代,评估基于POC-CCA检测的血吸虫病治疗策略对儿童生长和母亲血红蛋白的影响。干预组在孕期、产后9个月及婴儿9个月时接受POC-CCA-TBST,对照组随访程序相同但不含TBST,所有参与者在产后24个月接受TBST。

要点

  • 在马达加斯加中高流行区评估基于POC-CCA检测的吡喹酮治疗策略。
  • 纳入5200名孕妇及其后代,在40个初级卫生保健中心开展整群随机对照III期试验。
  • 主要关注儿童生长和母亲血红蛋白,所有参与者在产后24个月接受TBST。

核心结论

  • 该试验旨在评估POC-CCA-TBST策略对控制幼儿和母亲血吸虫病的效果。

研究设计与样本

  • 两臂、整群随机、对照III期试验,纳入5200名妇女及其后代,在马达加斯加40个初级卫生保健中心开展,纳入地点为曼氏血吸虫中高流行区。

主要发现

  • 干预组在孕期和产后9个月为妇女提供POC-CCA-TBST策略,婴儿在9月龄时接受该策略;对照组研究访视程序相同但不含POC-CCA-TBST程序。
  • 所有参与者在产后24个月接受POC-CCA-TBST。

临床怎么用

  • 该试验评估将孕妇及其2岁以下儿童纳入血吸虫病控制规划的策略,使用快速诊断检测。
  • 试验包括针对临床试验和大规模干预研究的本地能力建设。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mass drug administration (MDA) of praziquantel is one of the main control measures against human schistosomiasis. Although there are claims for including pregnant women, infants and children under the age of 5 years in high-endemic regions in MDA campaigns, they are usually not treated without a diagnosis. Diagnostic tools identifying infections at the primary health care centre (PHCC) level could therefore help to integrate these vulnerable groups into control programmes. freeBILy (fast and reliable easy-to-use-diagnostics for eliminating bilharzia in young children and mothers) is an international consortium focused on implementing and evaluating new schistosomiasis diagnostic strategies. In Madagascar, the study aims to determine the effectiveness of a test-based schistosomiasis treatment (TBST) strategy for pregnant women and their infants and children up until the age of 2 years. METHODS: A two-armed, cluster-randomized, controlled phase III trial including 5200 women and their offspring assesses the impact of TBST on child growth and maternal haemoglobin in areas of medium to high endemicity of Schistosoma mansoni. The participants are being tested with the point of care-circulating cathodic antigen (POC-CCA) test, a commercially available urine-based non-invasive rapid diagnostic test for schistosomiasis. In the intervention arm, a POC-CCA-TBST strategy is offered to women during pregnancy and 9 months after delivery, for their infants at 9 months of age. In the control arm, study visit procedures are the same, but without the POC-CCA-TBST procedure. All participants are being offered the POC-CCA-TBST 24 months after delivery. This trial is being integrated into the routine maternal and child primary health care programmes at 40 different PHCC in Madagascar's highlands. The purpose of the trial is to assess the effectiveness of the POC-CCA-TBST for controlling schistosomiasis in young children and mothers. DISCUSSION: This trial assesses a strategy to integrate pregnant women and their children under the age of 2 years into schistosomiasis control programmes using rapid diagnostic tests. It includes local capacity building for clinical trials and large-scale intervention research. TRIAL REGISTRATION: Pan-African Clinical Trial Register PACTR201905784271304. Retrospectively registered on 15 May 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fusco D, Rakotozandrindrainy R, Rakotoarivelo RA, et al. A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar. Trials. 2021. PMID: 34801082. doi:10.1186/s13063-021-05769-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。